Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes

DISCOVER is a global programme of observational research that includes patients with type 2 diabetes initiating second-line glucose-lowering therapy from 38 countries worldwide, including many with little or no previous epidemiological data available. More than 15,000 patients were followed-up for 3 years, and comprehensive data were collected using a standardized electronic case report form at enrolment, and 6, 12, 24 and 36 months. The study has formed the basis for a long-term registry that is intended to expand the geographic and clinical scope of the study and allow data collection beyond 3 years.

Source: Primary Care Diabetes - August 5, 2023 Category: Primary Care Authors: Pernilla Aarskog, Javier Cid-Ruzafa, Hungta Chen, Peter Fenici, Larisa Ramirez Gutierrez, Niklas Hammar, Jes ús Medina, Esther Pascual, Gabriela Luporini Saraiva, Filip Surmont, Stephen Sweet, Linong Ji, Kamlesh Khunti, Andrew Cooper Source Type: research